Two Sigma Securities »

Aeglea Biotherapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $346k 6.9k 50.44

More positions owned by Two Sigma Securities

Ishares Tr Core Us Aggbd Et (AGG)
Amazon (AMZN)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Tesla Motors (TSLA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Tips Bd Etf (TIP)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr Gold Tr Gold Shs (GLD)
Norfolk Southern (NSC)

View all positions for Two Sigma Securities

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Driehaus Capital Management
State Street Corporation
Paradigm Biocapital Advisors
Commodore Capital
TCG Crossover Management
Tang Capital Management
Capital Research and Management Company - Division 3

View all funds holding Aeglea Biotherapeutics